Exelixis (EXEL) Shows Strength: Stock Adds 8.2% in Session – Tale of the Tape

ZacksExelixis, Inc. (EXEL) was a big mover last session, as its shares rose over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $3.33 to $6.31 in the past one-month time frame.

Over the last 30 days, the company witnessed a mixed record of one positive and one negative estimate revision while the Zacks Consensus Estimate remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Exelixis currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Another favorably-ranked biomedical stock is Actelion Ltd. (ALIOF) with a Zacks Rank #1 (Strong Buy).

Is EXEL going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply